Stellate cell expression of SPARC-related modular calcium-binding protein 2 is associated with human non-alcoholic fatty liver disease severity

2022 Younossi, 2019, The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a systematic review and meta-analysis, J Hepatol, 71, 793, 10.1016/j.jhep.2019.06.021 Hagstrom, 2020, Health care costs of patients with biopsy-confirmed nonalcoholic fatty liver disease are nearly twice those of matched controls, Clin Gastroenterol Hepatol, 18, 1592, 10.1016/j.cgh.2019.10.023 O'Hara, 2020, Cost of non-alcoholic steatohepatitis in Europe and the USA: the GAIN study, JHEP Rep, 2 Matteoni, 1999, Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity, Gastroenterology, 116, 1413, 10.1016/S0016-5085(99)70506-8 Campos, 2008, A clinical scoring system for predicting nonalcoholic steatohepatitis in morbidly obese patients, Hepatology, 47, 1916, 10.1002/hep.22241 Kleiner, 2005, Design and validation of a histological scoring system for nonalcoholic fatty liver disease, Hepatology, 41, 1313, 10.1002/hep.20701 McGill, 1990, A 21-year experience with major hemorrhage after percutaneous liver biopsy, Gastroenterology, 99, 1396, 10.1016/0016-5085(90)91167-5 Vuppalanchi, 2009, Effects of liver biopsy sample length and number of readings on sampling variability in nonalcoholic Fatty liver disease, Clin Gastroenterol Hepatol, 7, 481, 10.1016/j.cgh.2008.12.015 Ratziu, 2005, Sampling variability of liver biopsy in nonalcoholic fatty liver disease, Gastroenterology, 128, 1898, 10.1053/j.gastro.2005.03.084 Davison, 2020, Suboptimal reliability of liver biopsy evaluation has implications for randomized clinical trials, J Hepatol, 73, 1322, 10.1016/j.jhep.2020.06.025 Wong, 2018, Noninvasive biomarkers in NAFLD and NASH - current progress and future promise, Nat Rev Gastroenterol Hepatol, 15, 461, 10.1038/s41575-018-0014-9 Tsuchida, 2017, Mechanisms of hepatic stellate cell activation, Nat Rev Gastroenterol Hepatol, 14, 397, 10.1038/nrgastro.2017.38 Abdelaziz, 2015, Tissue inhibitors of metalloproteinase-1 and 2 and obesity related non-alcoholic fatty liver disease: is there a relationship, Digestion, 92, 130, 10.1159/000439083 Boyle, 2019, Performance of the PRO-C3 collagen neo-epitope biomarker in non-alcoholic fatty liver disease, JHEP Rep, 1, 188, 10.1016/j.jhepr.2019.06.004 Luo, 2018, An evaluation of the collagen fragments related to fibrogenesis and fibrolysis in nonalcoholic steatohepatitis, Sci Rep, 8, 10.1038/s41598-018-30457-y Saekmose, 2015, Microfibrillar-associated protein 4: a potential biomarker for screening for liver fibrosis in a mixed patient cohort, PLoS One, 10, 10.1371/journal.pone.0140418 Nascimbeni, 2020, Clinical validation of the FLIP algorithm and the SAF score in patients with non-alcoholic fatty liver disease, J Hepatol, 72, 828, 10.1016/j.jhep.2019.12.008 Dobin, 2013, STAR: ultrafast universal RNA-seq aligner, Bioinformatics, 29, 15, 10.1093/bioinformatics/bts635 Liao, 2014, featureCounts: an efficient general purpose program for assigning sequence reads to genomic features, Bioinformatics, 30, 923, 10.1093/bioinformatics/btt656 Andrews, 2019 Ewels, 2016, MultiQC: summarize analysis results for multiple tools and samples in a single report, Bioinformatics, 32, 3047, 10.1093/bioinformatics/btw354 Ziegenhain, 2021, BAMboozle removes genetic variation from human sequence data for open data sharing, Nat Commun, 12, 6216, 10.1038/s41467-021-26152-8 Ramachandran, 2019, Resolving the fibrotic niche of human liver cirrhosis at single-cell level, Nature, 575, 512, 10.1038/s41586-019-1631-3 MacParland, 2018, Single cell RNA sequencing of human liver reveals distinct intrahepatic macrophage populations, Nat Commun, 9, 4383, 10.1038/s41467-018-06318-7 Payen, 2021, Single-cell RNA sequencing of human liver reveals hepatic stellate cell heterogeneity, JHEP Rep, 3 Hao, 2021, Integrated analysis of multimodal single-cell data, Cell, 184, 3573, 10.1016/j.cell.2021.04.048 McGinnis, 2019, DoubletFinder: doublet detection in single-cell RNA sequencing data using artificial nearest neighbors, Cell Syst, 8, 329, 10.1016/j.cels.2019.03.003 Korsunsky, 2019, Fast, sensitive and accurate integration of single-cell data with Harmony, Nat Methods, 16, 1289, 10.1038/s41592-019-0619-0 Dominguez Conde, 2022, Cross-tissue immune cell analysis reveals tissue-specific features in humans, Science, 376, 10.1126/science.abl5197 Robin, 2011, pROC: an open-source package for R and S+ to analyze and compare ROC curves, BMC Bioinformatics, 12, 77, 10.1186/1471-2105-12-77 Govaere, 2020, Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis, Sci Transl Med, 12, 10.1126/scitranslmed.aba4448 Terkelsen, 2020, Transcriptional dynamics of hepatic sinusoid-associated cells after liver injury, Hepatology, 72, 2119, 10.1002/hep.31215 Gong, 2019, Gpnmb secreted from liver promotes lipogenesis in white adipose tissue and aggravates obesity and insulin resistance, Nat Metab, 1, 570, 10.1038/s42255-019-0065-4 Wang, 2021, Single-cell and bulk transcriptomics of the liver reveals potential targets of NASH with fibrosis, Sci Rep, 11 Dobie, 2019, Single-cell transcriptomics uncovers zonation of function in the mesenchyme during liver fibrosis, Cell Rep, 29, 1832, 10.1016/j.celrep.2019.10.024 Bracht, 2015, Analysis of disease-associated protein expression using quantitative proteomics-fibulin-5 is expressed in association with hepatic fibrosis, J Proteome Res, 14, 2278, 10.1021/acs.jproteome.5b00053 Chandran, 2022, Circulating TREM2 as a non-invasive diagnostic biomarker for NASH in patients with elevated liver stiffness, Hepatology, 00, 1 Hendrikx, 2022, Soluble TREM2 levels reflect the recruitment and expansion of TREM2+ macrophages that localize to fibrotic areas and limit NASH, J Hepatol, 77, 1373, 10.1016/j.jhep.2022.06.004 Vannahme, 2003, Characterization of SMOC-2, a modular extracellular calcium-binding protein, Biochem J, 373, 805, 10.1042/bj20030532 Bornstein, 2009, Matricellular proteins: an overview, J Cel Commun Signal, 3, 163, 10.1007/s12079-009-0069-z Bornstein, 2002, Matricellular proteins: extracellular modulators of cell function, Curr Opin Cel Biol, 14, 608, 10.1016/S0955-0674(02)00361-7 Luo, 2018, Suppression of SMOC2 reduces bleomycin (BLM)-induced pulmonary fibrosis by inhibition of TGF-beta1/SMADs pathway, Biomed Pharmacother, 105, 841, 10.1016/j.biopha.2018.03.058 Su, 2016, Smoc2 potentiates proliferation of hepatocellular carcinoma cells via promotion of cell cycle progression, World J Gastroenterol, 22, 10053, 10.3748/wjg.v22.i45.10053 Liu, 2008, The SPARC-related factor SMOC-2 promotes growth factor-induced cyclin D1 expression and DNA synthesis via integrin-linked kinase, Mol Biol Cel, 19, 248, 10.1091/mbc.e07-05-0510 Gerarduzzi, 2017, Silencing SMOC2 ameliorates kidney fibrosis by inhibiting fibroblast to myofibroblast transformation, JCI Insight, 2, 10.1172/jci.insight.90299 Schmidt, 2021, Cadherin-11, Sparc-related modular calcium binding protein-2, and Pigment epithelium-derived factor are promising non-invasive biomarkers of kidney fibrosis, Kidney Int, 100, 672, 10.1016/j.kint.2021.04.037 Yuting, 2019, Secreted modular calcium-binding protein 2 promotes high fat diet (HFD)-induced hepatic steatosis through enhancing lipid deposition, fibrosis and inflammation via targeting TGF-beta1, Biochem Biophys Res Commun, 509, 48, 10.1016/j.bbrc.2018.12.006 Mederacke, 2013, Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology, Nat Commun, 4, 2823, 10.1038/ncomms3823 Wang, 2021, TGF-beta1/SMOC2/AKT and ERK axis regulates proliferation, migration, and fibroblast to myofibroblast transformation in lung fibroblast, contributing with the asthma progression, Hereditas, 158, 47, 10.1186/s41065-021-00213-w Marcher, 2019, Transcriptional regulation of hepatic stellate cell activation in NASH, Sci Rep, 9, 2324, 10.1038/s41598-019-39112-6 Ekstedt, 2015, Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up, Hepatology, 61, 1547, 10.1002/hep.27368 Samuel, 2018, Nonalcoholic fatty liver disease as a nexus of metabolic and hepatic diseases, Cell Metab, 27, 22, 10.1016/j.cmet.2017.08.002 Lan, 2013, Vascular fibrosis in atherosclerosis, Cardiovasc Pathol, 22, 401, 10.1016/j.carpath.2013.01.003 Henderson, 2020, Fibrosis: from mechanisms to medicines, Nature, 587, 555, 10.1038/s41586-020-2938-9 Schuler, 2021, Extensive remodeling of the extracellular matrix during aging contributes to age-dependent impairments of muscle stem cell functionality, Cel Rep, 35